OHSU Updates in Hematology and Breast Cancer Conference CML ASH Update Michael J. Mauro, MD.
DR Discontinuation of second generation tyrosine kinase inhibitors CML and MPDs UK national meeting Newcastle, March 1 st, 2013 Dr Delphine Rea Service.
